The Cooper Companies, Inc - Asset Resilience Ratio
The Cooper Companies, Inc (COO) has an Asset Resilience Ratio of 0.00% as of July 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See COO working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2001–2023)
This chart shows how The Cooper Companies, Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see The Cooper Companies, Inc (COO) total assets.
Liquid Assets Composition Over Time
This chart breaks down The Cooper Companies, Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read debt load of The Cooper Companies, Inc for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $-200.00K | -0.0% |
| Total Liquid Assets | $-200.00K | 0.00% |
Asset Resilience Insights
- Limited Liquidity: The Cooper Companies, Inc maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
The Cooper Companies, Inc Industry Peers by Asset Resilience Ratio
Compare The Cooper Companies, Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
SARTORIUS (UNSP.ADS)/1/5
F:SRT0 |
Medical Instruments & Supplies | 0.26% |
|
Pegavision
TW:6491 |
Medical Instruments & Supplies | 17.14% |
|
Mingyue Optical Lens Co.Ltd.
SHE:301101 |
Medical Instruments & Supplies | 47.21% |
|
Shanghai Kindly Entrp Dvlp Grp
SHG:603987 |
Medical Instruments & Supplies | 0.01% |
|
Vizionfocus Inc.
TW:4771 |
Medical Instruments & Supplies | 3.24% |
|
AVE Science & Technology Co Ltd
SHG:688067 |
Medical Instruments & Supplies | 24.13% |
|
Medeon Biodesign
TWO:6499 |
Medical Instruments & Supplies | 32.68% |
|
Nextgen
TA:NXGN |
Medical Instruments & Supplies | 3.13% |
Annual Asset Resilience Ratio for The Cooper Companies, Inc (2001–2023)
The table below shows the annual Asset Resilience Ratio data for The Cooper Companies, Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-10-31 | 0.00% | $100.00K | $11.66 Billion | -1.20pp |
| 2022-10-31 | 1.20% | $138.20 Million | $11.49 Billion | +0.20pp |
| 2021-10-31 | 1.00% | $95.90 Million | $9.61 Billion | -0.72pp |
| 2020-10-31 | 1.72% | $115.90 Million | $6.74 Billion | +0.30pp |
| 2019-10-31 | 1.42% | $89.00 Million | $6.27 Billion | +0.11pp |
| 2018-10-31 | 1.31% | $80.20 Million | $6.11 Billion | -0.52pp |
| 2017-10-31 | 1.83% | $88.80 Million | $4.86 Billion | -0.42pp |
| 2016-10-31 | 2.25% | $100.80 Million | $4.48 Billion | -- |
| 2015-10-31 | 0.00% | $0.00 | $4.46 Billion | -- |
| 2014-10-31 | 0.00% | $0.00 | $4.46 Billion | -- |
| 2013-10-31 | 0.00% | $0.00 | $3.14 Billion | -- |
| 2012-10-31 | 0.00% | $0.00 | $2.94 Billion | -- |
| 2011-10-31 | 0.00% | $0.00 | $2.62 Billion | -- |
| 2010-10-31 | 0.00% | $0.00 | $2.53 Billion | -- |
| 2004-10-31 | 0.23% | $1.83 Million | $811.56 Million | -0.59pp |
| 2003-10-31 | 0.81% | $5.75 Million | $705.56 Million | +0.33pp |
| 2002-10-31 | 0.48% | $2.75 Million | $571.12 Million | -1.53pp |
| 2001-10-31 | 2.01% | $7.98 Million | $396.85 Million | -- |
About The Cooper Companies, Inc
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and wome… Read more